Synapse - Manish Shah

Results (177)

Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors

Journal Article

Rathkopf, D.; Dickson, M. A.; Feldman, D. R.; Carvajal, R. D.; Shah, M. A.; Wu, N.; Lefkowitz, R.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
Clinical Cancer Research (2009)

Fulltext@MSK | Save

Endoscopic Ultrasound Can Improve the Selection for Laparoscopy in Patients with Localized Gastric Cancer

Journal Article

Power, D. G.; Schattner, M.; Gerdes, H.; Brenner, B.; Markowitz, A. J.; Capanu, M.; Coit, D. G.; Brennan, M.; Kelsen, D. P.; Shah, M. A.
Journal of the American College of Surgeons (2009)

Fulltext@MSK | Save

Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: Gene expression analysis with pathologic validation

Journal Article

Jhawer, M.; Coit, D.; Brennan, M.; Qin, L. X.; Gonen, M.; Klimstra, D.; Tang, L.; Kelsen, D. P.; Shah, M. A.
American Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

How should we care for elderly cancer patients? - The Ades article reviewed [Adjuvant chemotherapy for colon cancer in the elderly: Moving from evidence to practice]

Journal Article

Feilchenfeldt, J.; Shah, M. A.
Oncology (Norwalk) (2009)

Fulltext@MSK | Save

A phase II study of flavopiridol (alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer

Journal Article

Carvajal, R. D.; Tse, A.; Shah, M. A.; Lefkowitz, R. A.; Gonen, M.; Gilman-Rosen, L.; Kortmansky, J.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
Pancreatology (2009)

Fulltext@MSK | Save

A phase II study of docetaxel (D) followed by flavopiridol (F) in advanced, gemcitabine-refractory pancreatic cancer (PC)

Meeting Abstract

Carvajal, R. D.; Shah, M. A.; Tse, A.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Docetaxel clearance and cisplatin administration: Implications for toxicity of docetaxel, cisplatin, and fluorouracil (DCF) in gastric cancer

Meeting Abstract

Power, D. G.; Wu, N.; Qin, W.; Sully, D.; Cisek, C.; Randazzo, J.; Ritch, P. S.; Jhawer, M. P.; Kelsen, D. P.; Shah, M. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort

Meeting Abstract

Shah, M. A.; Sheehy, E.; Harlan, M.; Randazzo, J.; Perera, R. J.; Pascarelli, K.; Kemeny, M. M.; Schrag, D.; Coit, D. G.; Kelsen, D. P.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Preliminary activity of XL880, a dual MET/VEGFR2 inhibitor, in MET amplified poorly differentiated gastric cancer (PDGC): Interim results of a multicenter phase II study

Meeting Abstract

Jhawer, M. P.; Kindler, H. L.; Wainberg, Z. A.; Hecht, J. R.; Kerr, R. O.; Ford, J. M.; Henderson, C.; Mueller, T.; Keer, H. N.; Shah, M. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A phase I study of FOLFOX administered with flavopiridol (F) in patients with refractory solid tumors

Meeting Abstract

Dickson, M. A.; Carvajal, R. D.; Shah, M. A.; Cane, L. M.; Dials, H. J.; Schwartz, G. K.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save